Two critical Next.js flaws enable unauthenticated remote code execution on Windows-hosted apps using the Image Optimization ...

Match ends, Ajax 3, Shelbourne 1. Attempt missed. Anton Gaaei (Ajax) right footed shot from the centre of the box misses to the right. Assisted by Oliver Edvardsen with a cross. Attempt missed. Marcos ...

Ajax host Shelbourne at the Johan Cruijff ArenA on Thursday in the first leg of their UEFA Conference League third qualifying round tie. The Dutch giants head into the match full of confidence after ...

Ajax face Shelbourne FC on Thursday evening in the third qualifying round of the Conference League. Kick-off at the sold-out Johan Cruijff ArenA is at 8pm, and the match can be followed live on ...

IHOP is finally coming to Ajax and it’s set to open this summer. It has been three years since a “coming soon” sign was posted at a different location in Ajax and stirred excitement among local ...

Windows 11’s File Explorer finally features a file size display that’s easily readable at a glance. Additionally, two important menu items are returning to the right-click menu in File Explorer. There ...

An inmate being housed at the Moshannon Valley Processing Center near Philipsburg is continuing to complain about the facility's lack of mental health care and other conditions of his confinement that ...

For tax professionals, access to timely and accurate IRS data is not a convenience — it is essential to effective representation, taxpayer rights and voluntary compliance. At the center of that access ...

LONDON, April 28 (Reuters) - Britain's defence readiness minister Luke Pollard said he had agreed to restart the army's acceptance of Ajax armoured vehicles from General Dynamics with ‌strict controls ...

Eli Lilly said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up to $2.3 billion in cash, as the U.S. drugmaker looks to expand its oncology pipeline. Lilly has been ...

April 27 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Monday it would buy privately held cancer drug developer Ajax Therapeutics for up ‌to $2.3 billion in cash, as the U.S. drugmaker looks to ...